Wild-Type Reovirus, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT02514382 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Plasma Cell Myeloma
Refractory Plasma Cell Myeloma

Interventions

DRUG: Bortezomib
DRUG: Dexamethasone
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
BIOLOGICAL: Wild-type Reovirus

Sponsor

University of Southern California

Collaborators

[object Object]
[object Object]